Breast Cancer Is Rising in Pregnant Women and New Mothers
When we talk about breast cancer, pregnancy is rarely part of the conversation. We tend to think of breast cancer as a disease of older age, not something that happens to young…
Read More ➝
Posts
We’re Moving for the Mission
This October, don’t just wear pink—take action. Support MiraKind’s annual run/walk fundraiser to advance groundbreaking genetic research that’s changing how we understand, prevent, and treat cancer. Team MiraKind Is On the Move!…
Read More ➝
Making Treatment Decisions in Localized Prostate Cancer: Surgery vs. Radiation
Deciding what to do after a diagnosis of localized prostate cancer can be difficult. For some slow-growing cancers, active surveillance—closely monitoring the cancer without immediate treatment—may be a safe and effective option….
Read More ➝
How Genomic Testing Helps Guide Localized Prostate Cancer Decisions: Active Surveillance versus Treatment
Prostate cancer is one of the most common cancers in men, but most cases do not need immediate treatment. Some grow so slowly they may never cause symptoms or affect long-term health….
Read More ➝
New Study Suggests Some Breast Cancer Patients May Safely Avoid Lymph Node Radiation After a Complete Response to Chemotherapy
A new clinical trial published in the New England Journal of Medicine may change how some breast cancer patients are treated with radiation after chemotherapy and surgery. We spoke with Dr. Terry…
Read More ➝
How Do Checkpoint Inhibitors Help the Immune System Recognize and Destroy Cancer Cells?
Your immune system protects you from threats like viruses, bacteria, and even cancer. However, some cancer cells have developed clever ways to avoid detection. They disguise themselves to look like normal cells,…
Read More ➝
Discoveries from ASCO that are Shaping Cancer Care
We recently attended the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting—one of the world’s largest gatherings dedicated to advancing cancer care. This year’s event showcased a wave of innovation aimed…
Read More ➝
How Genetics Can Help Personalize Cancer Treatment—Insights from ASCO 2025
How can inherited genetic differences help predict who’s more likely to benefit from cancer treatment—or experience severe side effects? That question is at the heart of two new studies we recently shared…
Read More ➝
The Unseen Battle: Emotional and Mental Health Challenges in Cancer
May is Mental Health Awareness Month, and we’re taking this opportunity to focus on the connection between cancer and mental health. When most people hear the word “cancer,” they think of treatments,…
Read More ➝
Current Challenges and Advances in Cancer Treatment
Cancer treatment often involves multiple options based on general data about how most patients will respond to therapy. However, this approach may not be effective for everyone, as treatment responses and side…
Read More ➝
Why Are Autoimmune Diseases More Common in Women? The Estrogen Connection
Did you know that 80% of people affected by autoimmune diseases are women? This stark gender difference raises an important question: why are women more likely to develop autoimmune diseases than men?…
Read More ➝
Does HRT Lower Heart Disease Risk? The Truth About Estrogen
Heart disease is the leading cause of death for women in the United States. While it can affect women at any age, it increases after menopause. In part, this is due to…
Read More ➝
Managing Radiation Therapy Side Effects with Genetic Testing
Radiation therapy is a successful treatment against many types of cancer. Unfortunately, some survivors will experience radiation toxicity from the treatment, with the most problematic side effects manifesting years later and potentially…
Read More ➝
MiraKind Year in Review
Happy Holidays! As we reflect on 2024, we’d like to share some of our achievements with you and express our gratitude to our patients and donors. These successes would not have been…
Read More ➝
Personalizing Your Prostate Cancer Treatment With Genetic Testing: An Interview with Dr. Joanne Weidhaas
November is Prostate Cancer Awareness Month, so this month we’ve interviewed MiraKind’s founder, Dr. Joanne Weidhaas, about personalizing prostate cancer treatment and how patients can personalize their treatment choices with a new…
Read More ➝
